1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
39.42%
Positive revenue growth while 6247.T is negative. John Neff might see a notable competitive edge here.
53.62%
Positive gross profit growth while 6247.T is negative. John Neff would see a clear operational edge over the competitor.
250.85%
EBIT growth above 1.5x 6247.T's 134.11%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
256.00%
Positive operating income growth while 6247.T is negative. John Neff might view this as a competitive edge in operations.
171.88%
Net income growth under 50% of 6247.T's 468.13%. Michael Burry would suspect the firm is falling well behind a key competitor.
171.96%
EPS growth under 50% of 6247.T's 468.36%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
171.96%
Diluted EPS growth under 50% of 6247.T's 468.36%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-0.00%
Reduced diluted shares while 6247.T is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-90.26%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-27.58%
Negative 5Y CAGR while 6247.T stands at 4.68%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-44.20%
Negative 3Y CAGR while 6247.T stands at 13.02%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
100.00%
Positive long-term OCF/share growth while 6247.T is negative. John Neff would see a structural advantage in sustained cash generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
101.52%
Net income/share CAGR 1.25-1.5x 6247.T's 87.63%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
-49.90%
Negative 5Y net income/share CAGR while 6247.T is 1794.57%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-72.56%
Negative 3Y CAGR while 6247.T is 270.45%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
214.79%
5Y equity/share CAGR above 1.5x 6247.T's 24.78%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
11.06%
3Y equity/share CAGR above 1.5x 6247.T's 6.78%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
32.99%
AR growth well above 6247.T's 2.02%. Michael Burry fears inflated revenue or higher default risk in the near future.
16.65%
Inventory growth well above 6247.T's 12.71%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
16.62%
Asset growth above 1.5x 6247.T's 3.20%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
6.81%
BV/share growth above 1.5x 6247.T's 1.96%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
18.95%
Debt growth of 18.95% while 6247.T is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
4.19%
R&D growth of 4.19% while 6247.T is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
0.31%
SG&A declining or stable vs. 6247.T's 4.61%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.